3-Phosphoglycerate dehydrogenase deficiency: description of two new cases in Tunisia and review of the literature.

Ichraf Kraoua, Elsa Wiame, Lilia Kraoua, Fehmi Nasrallah, Hanen Benrhouma, Aida Rouissi, Ilhem Turki, Habiba Chaabouni, Gilbert Briand, Naziha Kaabachi, Emile Van Schaftingen, Neziha Gouider-Khouja

Journal: Neuropediatrics 2014;44(5):281-5

PMID: 23564319

Abstract

3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency is a rare autosomal recessive disorder of serine biosynthesis. It is typically characterized by congenital microcephaly, intractable seizures of infantile onset, and severe psychomotor retardation. Diagnosis is suspected on decreased l-serine levels in plasma and cerebrospinal fluid (CSF) and confirmed by genetic study. Early diagnosis in index cases allows supplementation in serine and prevention of fixed lesions. Prenatal diagnosis and genetic counseling allows prevention of secondary cases. We report on the two first unrelated Tunisian families with 3-PGDH deficiency confirmed by biochemical and genetic study. We discuss clinical, biochemical, imaging, electroencephalographic, and therapeutic aspects and review the literature.

Georg Thieme Verlag KG Stuttgart · New York.

Address: Department of Child and Adolescent Neurology and UR 06/11, National Institute Mongi Ben Hmida of Neurology, Tunis, Tunisia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.